HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)
China flag China · Delayed Price · Currency is CNY
3.380
+0.050 (1.50%)
Feb 24, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Chemical Medicine
2.25B2.52B2.97B2.98B2.76B
Chemical Medicine Growth
-10.47%-15.15%-0.36%7.97%-
Traditional Chinese Medicine
182.09M100.96M134.54M148.43M279.64M
Traditional Chinese Medicine Growth
80.36%-24.96%-9.36%-46.92%-
Others
5.02M7.80M6.73M19.45M17.64M
Others Growth
-35.59%15.98%-65.43%10.24%-
Total
2.44B2.63B3.11B3.15B3.05B
Total Growth
-7.06%-15.51%-1.19%2.96%-39.55%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
China
2.44B2.62B3.10B3.14B3.05B
China Growth
-7.12%-15.42%-1.23%2.98%-39.59%
Overseas
3.75M2.36M6.11M4.88M5.50M
Overseas Growth
58.81%-61.30%25.07%-11.23%-6.62%
Total
2.44B2.63B3.11B3.15B3.05B
Total Growth
-7.06%-15.51%-1.19%2.96%-39.55%
Source: S&P Global Market Intelligence.